Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00238823 · ClinicalTrials.gov registry record
Cryoablation Versus Radiofrequency Ablation
A clinical trial, sponsored by Children's Healthcare of Atlanta.
- Terminated
- Registry status
- 50
- Enrollment target
NCT00238823: Clinical Trial study, sponsored by Children's Healthcare of Atlanta.
NCT00238823 is a clinical trial that was terminated before completion, run by Children's Healthcare of Atlanta. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00238823 was terminated before completion, sponsored by Children's Healthcare of Atlanta.
- TERMINATED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The purpose of this retrospective study is to describe why and when we used cryo and why we crossed over when we used both RFA and cryo. It is also to determine if there is some predictor that would make us say one patient would be better served with one technique than another and to describe our overall acute success rate and then our 6-month recurrence rate with cryo ablation and compare it to our known success rate with RFA.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2004-01 |
| Est. Completion | 2004-12 |
Why NCT00238823 stopped before completion
NCT00238823 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00238823 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00238823 about?
NCT00238823 is a clinical study titled "Cryoablation Versus Radiofrequency Ablation". The purpose of this retrospective study is to describe why and when we used cryo and why we crossed over when we used both RFA and cryo. It is also to determine if there is some predictor that would make us say one patient would be better served with one technique than another and to describe our ov...
What is the current status of trial NCT00238823?
This trial is currently terminated. The enrollment target is 50 participants. The study started on 2004-01. Estimated completion is 2004-12.
Who is sponsoring clinical trial NCT00238823?
This trial is sponsored by Children's Healthcare of Atlanta, which has 80 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia